ancotil 10 mg/ml infuusioneste
f.hoffmann-la roche ltd - flucytosinum - infuusioneste - 10 mg/ml - flusytosiini
ancotil 500 mg tabletti
f.hoffmann-la roche ltd - flucytosinum - tabletti - 500 mg - flusytosiini
metosinat 23.75 mg depottabletti
hexal ag - metoprololi succinas - depottabletti - 23.75 mg - metoprololi
metosinat 47.5 mg depottabletti
hexal ag - metoprololi succinas - depottabletti - 47.5 mg - metoprololi
metosinat 95 mg depottabletti
hexal ag - metoprololi succinas - depottabletti - 95 mg - metoprololi
metosinat 142.5 mg depottabletti
hexal ag - metoprololi succinas - depottabletti - 142.5 mg - metoprololi
metosinat 190 mg depottabletti
hexal ag - metoprololi succinas - depottabletti - 190 mg - metoprololi
slentrol
zoetis belgium sa - dirlotapidi - antiobesity preparations, excl. ruokavalion tuotteita - koirat - apuna ylipainoisuuden ja lihavuuden hallinnassa aikuisille koirille. voidaan käyttää osana yleistä painonhallintaohjelmaa, johon sisältyy myös asianmukaisia ruokavalion muutoksia ja harjoittelua.
zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.
bricanyl turbuhaler 0.5 mg/annos inhalaatiojauhe
astrazeneca oy - terbutaline sulfate - inhalaatiojauhe - 0.5 mg/annos - terbutaliini